Last updated 2024-12-22 03:59:09 (EST)

Fundamental Analysis

By analyzing seasonally adjusted quarterly revenue, one can gauge the trend of stock. However, please note that stock prices can sometimes lead fundamental data, so it should be accompanied by other leading indicators for better judgment.

Quarterly Revenue Trend tooltip

Quarter-over-Quarter Growth Rate
of Seasonally Adjusted Quarterly Revenue

-27.1%


As of 2024-09-30

Basic Information

Basic information of individual stocks, as well as their respective sectors and industries.

Company Introduction

Business Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Industry

Sector
Healthcare
Industry
Medical - Devices

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.

warning